Dry mouth and its effects on the oral health of elderly people

Journal of the American Dental Association

Volumn 138, Issue 9 SUPPL., 2007, Pages S15-S20

  Turner, Michael D ^a   Ship, Jonathan A ^b  

^a NEW YORK UNIVERSITY   (United States)

^b NEW YORK UNIVERSITY COLLEGE OF DENTISTRY   (United States)

Author keywords

Aging; Cancer; Medications; Radiotherapy; Saliva; Salivary glands; Sj gren's syndrome; Xerostomia

Indexed keywords

AGED; HEALTH; HUMAN; REVIEW; XEROSTOMIA;

AGED; HUMANS; ORAL HEALTH; XEROSTOMIA;

EID: 34748884549     PISSN: 00028177     EISSN: None     Source Type: Journal    
DOI: 10.14219/jada.archive.2007.0358     Document Type: Review

References (29)

1. Ship JA, Pillemer SR, Baum BJ. Xerostomia and the geriatric patient. J Am Geriatr Soc 2002;50(3):535-43.
2. Fox PC. Autoimmune diseases and Sjögren's syndrome: an autoimmune exocrinopathy. Ann N Y Acad Sci 2007;1098:15-21.
3. Shiboski CH, Hodgson TA, Ship JA, Schiodt M. Management of salivary hypofunction during and after radiotherapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;103(supplement 1):S66-S73.
4. Bergdahl M. Salivary flow and oral complaints in adult dental patients. Community Dent Oral Epidemiol 2000;28(1):59-66.
5. von Bultzingslowen I, Sollecito TP, Fox PC, et al. Salivary dysfunction associated with systemic diseases: systematic review and clinical management recommendations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;103(supplement 1):S57-S65.
6. Ghezzi EM, Wagner-Lange LA, Schork MA, et al. Longitudinal influence of age, menopause, hormone replacement therapy, and other medications on parotid flow rates in healthy women. J Gerontol A Biol Sci Med Sci 2000;55(1):M34-M42.
7. Ghezzi EM, Ship JA. Aging and secretory reserve capacity of major salivary glands. J Dent Res 2003;82(10):844-8.
8. Sreebny LM, Schwartz SS. A reference guide to drugs and dry mouth: 2nd edition. Gerodontology 1997;14(1):33-47.
9. Närhi TO. Prevalence of subjective feelings of dry mouth in the elderly. J Dent Res 1994;73(1):20-5.
10. Thomson WM, Chalmers JM, Spencer AJ, Slade GD. Medication and dry mouth: findings from a cohort study of older people. J Public Health Dent 2000;60(1):12-20.
11. Epstein JB, Tsang AH, Warkentin D, Ship JA. The role of salivary function in modulating chemotherapy-induced oropharyngeal mucositis: a review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Ended 2002;94(1):39-44.
12. Meurman JH, Laine P, Lindqvist C, Teerenhovi L, Pyrhonen S. Five-year follow-up study of saliva, mutans streptococci, lactobacilli and yeast counts in lymphoma patients. Oral Oncol 1997;33(6):439-43.
13. Allweiss P, Braunstein GD, Katz A, Waxman A. Sialadenitis following I-131 therapy for thyroid carcinoma: concise communication. J Nucl Med 1984;25(7):755-8.
14. Eisbruch A, Ten Haken RK, Kim HM, Marsh LH, Ship JA. Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys 1999;45(3):577-87.
15. Vitali C, Bombardieri S, Jonsson R; European Study Group on Classification Criteria for Sjögren's Syndrome, et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61(6):554-8.
16. Pillemer SR, Matteson EL, Jacobsson LT, et al. Incidence of physician-diagnosed primary Sjögren syndrome in residents of Olmsted County, Minnesota. Mayo Clinic Proc 2001;76(6):593-9.
17. Fox RI, Stern M, Michelson P. Update in Sjögren syndrome. Curr Opin Rheumatol 2000;12(5):391-8.
18. Kassan SS, Thomas TL, Moutsopoulos HM, et al. Increased risk of lymphoma in sicca syndrome. Ann Intern Med 1978;89(6):888-92.
19. Bell M, Askari A, Bookman A, et al. Sjögren's syndrome: a critical review of clinical management [published correction appears in J Rheumatol 1999;26(12):2718]. J Rheumatol 1999;26(9):2051-61.
20. Spielman AI, Ship JA. Taste and smell. In: Miles TS, Nauntofte B, Svensson P, eds. Clinical oral physiology. Copenhagen, Denmark: Quintessence; 2004:53-70.
21. Loesche WJ, Bromberg J, Terpenning MS, et al. Xerostomia, xerogenic medications and food avoidances in selected geriatric groups. J Am Geriatr Soc 1995;43(4):401-7.
22. Atkinson JC, Wu A. Salivary gland dysfunction: causes, symptoms, treatment. JADA 1994;125(4):409-16.
23. Fox PC. Management of dry mouth. Dent Clin North Am 1997;41(4):863-76.
24. Ship JA. Diagnosing, managing, and preventing salivary gland disorders. Oral Dis 2002;8(2):77-89.
25. Johnson JT, Ferretti GA, Nethery WJ, et al. Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer. N Engl J Med 1993;329(6):390-5.
26. Vivino FB, Al-Hashimi I, Khan Z, et al. Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjögren syndrome: a randomized, placebo-controlled, fixed-dose, multicenter trial. P92-01 Study Group. Arch Intern Med 1999;159(2):174-81.
27. Petrone D, Condemi JJ, Fife R, Gluck O, Cohen S, Dalgin P. A double-blind, randomized, placebo-controlled study of cevimeline in Sjögren's syndrome patients with xerostomia and keratoconjunctivitis sicca. Arthritis Rheum 2002;46(3):748-54.
28. Fife RS, Chase WF, Dore RK, et al. Cevimeline for the treatment of xerostomia in patients with Sjögren syndrome: a randomized trial. Arch Intern Med 2002;162(11):1293-300.
29. Scully C. Drug effects on salivary glands: dry mouth. Oral Dis 2003;9(4):165-76.